Heidi Hagen - Net Worth and Insider Trading

Heidi Hagen Net Worth

The estimated net worth of Heidi Hagen is at least $2,374 dollars as of 2024-11-13. Heidi Hagen is the Director of Alaunos Therapeutics Inc and owns about 973 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $2,374. Details can be seen in Heidi Hagen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Heidi Hagen has not made any transactions after 2021-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Heidi Hagen

To

Heidi Hagen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Heidi Hagen owns 2 companies in total, including Vericel Corp (VCEL) , and Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Heidi Hagen’s form 4 insider trades.

Insider Ownership Summary of Heidi Hagen

Ticker Comapny Transaction Date Type of Owner
VCEL Vericel Corp 2015-03-20 director
TCRT Alaunos Therapeutics Inc 2021-09-02 director

Heidi Hagen Latest Holdings Summary

Heidi Hagen currently owns a total of 1 stock. Heidi Hagen owns 973 shares of Alaunos Therapeutics Inc (TCRT) as of September 2, 2021, with a value of $2,374.

Latest Holdings of Heidi Hagen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRT Alaunos Therapeutics Inc 2021-09-02 973 2.44 2,374

Holding Weightings of Heidi Hagen


Heidi Hagen Form 4 Trading Tracker

According to the SEC Form 4 filings, Heidi Hagen has made a total of 1 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 158 shares on September 2, 2021, which cost Heidi Hagen around $41,835.

Insider Trading History of Heidi Hagen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Heidi Hagen Trading Performance

GuruFocus tracks the stock performance after each of Heidi Hagen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Heidi Hagen is -25.42%. GuruFocus also compares Heidi Hagen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Heidi Hagen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Heidi Hagen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Heidi Hagen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.95 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 7.92 LIMIT LIMIT LIMIT LIMIT LIMIT

Heidi Hagen Ownership Network

Ownership Network List of Heidi Hagen

No Data

Ownership Network Relation of Heidi Hagen

Insider Network Chart

Heidi Hagen Owned Company Details

What does Vericel Corp do?

Who are the key executives at Vericel Corp?

Heidi Hagen is the director of Vericel Corp. Other key executives at Vericel Corp include director & President and CEO Dominick Colangelo , Chief Medical Officer Jonathan Mark Hopper , and SVP & General Counsel Sean C. Flynn .

Vericel Corp (VCEL) Insider Trades Summary

Over the past 18 months, Heidi Hagen made no insider transaction in Vericel Corp (VCEL). Other recent insider transactions involving Vericel Corp (VCEL) include a net sale of 396,849 shares made by Dominick Colangelo , a net sale of 21,000 shares made by Zerbe Robert L Md , and a net sale of 47,768 shares made by Sean C. Flynn .

In summary, during the past 3 months, insiders sold 137,500 shares of Vericel Corp (VCEL) in total and bought 0 shares, with a net sale of 137,500 shares. During the past 18 months, 558,279 shares of Vericel Corp (VCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 558,279 shares.

Vericel Corp (VCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vericel Corp Insider Transactions

No Available Data

Heidi Hagen Mailing Address

Above is the net worth, insider trading, and ownership report for Heidi Hagen. You might contact Heidi Hagen via mailing address: Aastrom Biosciences, Inc., 24 Frank Lloyd Wright Drive, Ann Arbor Mi 48105.